UPDATE : Tuesday, March 19, 2019
상단여백
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China by Lee Han-soo 2019-02-11 11:23
Novo Nordisk has high expectations for GLP-1 receptor agonists by Kim Yun-mi 2019-02-08 17:11
‘Total homocysteine increases risk of cerebral infarction’ by Lee Han-soo 2019-02-08 16:13
Pangen wins Malaysia’s nod for epoetin alfa biosimilar by Lee Han-soo 2019-02-08 16:13
Kainos Medicine starts developing treatment for multiple system atrophy by Lee Han-soo 2019-02-08 11:47
라인
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’ by Lee Han-soo 2019-02-07 17:14
FDA starts inspecting SK Biopharm’s epilepsy treatment by Lee Han-soo 2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment by Lee Han-soo 2019-02-07 14:40
FDA OKs Daewoong’s BTX by Lee Han-soo 2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars by Lee Han-soo 2019-02-01 17:04
라인
Medytox, Daewoong continue to squabble over BTX by Lee Han-soo 2019-02-01 15:36
Samsung BioLogics posts ₩535.8 billion in 2018 sales by Lee Han-soo 2019-02-01 11:56
Santen Pharma to sell Huonland’s eye drop in China by Lee Han-soo 2019-02-01 11:56
Boryung Bio, CancerRop launch Wilson's disease screening test by Lee Han-soo 2019-02-01 10:59
AbClon transfers target antibody technology to GC Labcell by Lee Han-soo 2019-01-31 16:23
라인
Novo Nordisk’s growth hormone injection gets expanded coverage by Lee Han-soo 2019-01-31 15:18
Kwangdong dismisses rumors of terminating sales for Contrav by Lee Han-soo 2019-01-31 14:32
T&R Biofab’s 3D-printing medical device gets sales nod in Vietnam by Lee Han-soo 2019-01-31 12:46
Celltrion to export biosimilars to Latin America by Lee Han-soo 2019-01-31 11:12
Samsung Bioepis’ biosimilar sales in EU exceed $500 million by Lee Han-soo 2019-01-30 18:17
여백
여백
여백
Back to Top